Amoéba S.A. (EPA:ALMIB)

Market Cap	68.89M +65.7%
Revenue (ttm)	n/a
Net Income	-8.30M
EPS	n/a
Shares Out	68.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	209,623
Average Volume	308,002
Open	1.000
Previous Close	1.000
Day's Range	0.980 - 1.018
52-Week Range	0.782 - 1.444
Beta	0.05
RSI	54.64
Earnings Date	Mar 27, 2026

About Amoéba

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is based in Chassieu, France.

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2010
• Employees: 20
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMIB